We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

234 hedge funds and large institutions have $3.41B invested in Jazz Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 234 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

57% less call options, than puts

Call options by funds: $26.3M | Put options by funds: $60.9M

Holders
234
Holders Change
+234
Holders Change %
–
% of All Funds
7.64%
Holding in Top 10
10
Holding in Top 10 Change
+10
Holding in Top 10 Change %
% of All Funds
0.33%
New
234
Increased
–
Reduced
–
Closed
–
Calls
$26.3M
Puts
$60.9M
Net Calls
-$34.6M
Net Calls Change
-$34.6M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AAP
26
Ardsley Advisory Partners
Connecticut
$29.8M +$26.5M +433,500 New
AI
27
Axiom Investors
Connecticut
$29.8M +$26.5M +433,290 New
Bank of America
28
Bank of America
North Carolina
$29.7M +$26.4M +432,234 New
Lord, Abbett & Co
29
Lord, Abbett & Co
New Jersey
$29.6M +$26.3M +431,004 New
AAMU
30
Amundi Asset Management US
Massachusetts
$28.9M +$25.7M +421,059 New
Wellington Management Group
31
Wellington Management Group
Massachusetts
$26M +$23.1M +378,455 New
Ninety One (UK)
32
Ninety One (UK)
United Kingdom
$23.5M +$20.9M +342,462 New
Adage Capital Partners
33
Adage Capital Partners
Massachusetts
$23M +$20.5M +335,000 New
Axa
34
Axa
France
$22.7M +$20.2M +329,875 New
CCM
35
Consonance Capital Management
New York
$21.5M +$19.1M +312,858 New
BSA
36
Braun Stacey Associates
New York
$21.3M +$18.9M +309,910 New
Prudential Financial
37
Prudential Financial
New Jersey
$21.2M +$18.8M +308,315 New
TA
38
Teachers Advisors
New York
$20.5M +$18.2M +297,701 New
Morgan Stanley
39
Morgan Stanley
New York
$19.9M +$17.7M +289,743 New
CCP
40
Clough Capital Partners
Massachusetts
$18.9M +$16.8M +275,501 New
PC
41
PointState Capital
New York
$18.9M +$16.8M +275,000 New
Bank of Montreal
42
Bank of Montreal
Ontario, Canada
$18.5M +$16.4M +269,008 New
O
43
OppenheimerFunds
New York
$17.4M +$15.5M +253,176 New
HM
44
HealthCor Management
New York
$17.2M +$15.3M +250,000 New
Deutsche Bank
45
Deutsche Bank
Germany
$16.8M +$15M +244,974 New
Geode Capital Management
46
Geode Capital Management
Massachusetts
$15.2M +$13.5M +221,629 New
LBH
47
Lehman Brothers Holdings
New York
$14.6M +$13M +212,243 New
AP
48
Alydar Partners
Massachusetts
$13.7M +$12.2M +200,000 New
NIMC
49
NWQ Investment Management Company
California
$13.7M +$12.1M +198,679 New
Dimensional Fund Advisors
50
Dimensional Fund Advisors
Texas
$12.8M +$11.4M +186,684 New
1
2
3 4 5

JAZZ Hedge Fund Activity: Q2 2013 in Review

234 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q2 2013, worth a combined $3.41B.

Buyers outnumbered sellers: 234 funds opened new JAZZ positions and 0 closed out — a net gain of 234 holders — while 0 added to existing stakes and 0 trimmed.

  • 234 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $3.41B of Jazz Pharmaceuticals stock for Q2 2013.
  • 234 funds opened new Jazz Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +234 holders.

Based on aggregated 13F filings for Q2 2013.